Fareston Oral Tablet 60Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Fareston: Oral tablet (60mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15756.JPG
Fareston 60mg Tab
ProStrakan Inc.
Pill Identification: TO 60 
Drug Image file DrugItem_15756.JPG
Fareston 60mg Tab
ProStrakan Inc.
Pill Identification: TO 60 
Drug Image file DrugItem_16103.JPG
Fareston 60mg Tab
ProStrakan Inc.
Pill Identification: TO 60 

What is this Medicine?

TOREMIFENE (tore EM i feen) blocks the effects of estrogen. It is used to treat some types of breast cancer.

CVS Pharmacy Patient Statistics for Fareston: Oral tablet(60mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Fareston 60mg Tablet

NDC: 113990005
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer

Sometimes used for but not FDA approved for the following conditions:
Prostate Cancer Prophylaxis

Storage Information
Avoid exposure to heat
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Fareston 60mg Tablet
Drug Image file DrugItem_15756.JPG
ProStrakan Inc.
Pill Identification: TO 60 
Shape: round
Color: white
Drug Image file DrugItem_10580.JPG
ProStrakan Inc.
Pill Identification: TO 60 
Shape: round
Color: white

Reported Side Effects for Fareston 60mg Tablet

Blood Clot Incidence:
<1.5%*
Severity: SEVERE
Onset: DELAYED
Irritated Blood Vessels Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Brain Attack Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot In Lung Incidence:
<1.5%*
Severity: SEVERE
Onset: DELAYED
High Calcium Levels Incidence:
<3.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
1.0-1.5%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Double Vision Incidence:
1.5%*
Severity: MILD
Onset: EARLY
Abnormal Heart Rhythm Incidence:
1.5%*
Severity: SEVERE
Onset: EARLY
Keratopathy Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Bleeding Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Swelling Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
5.0-19.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Dry Eyes Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Discharge Incidence:
13.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Diaphoresis Incidence:
20.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
35.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Fareston

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5